Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

Abroad (travel likely)RecruitingPHASE1

Conditions

Prostate Cancer Patients · Non-castrate Prostate Cancer · Recurrent Prostate Cancer · Oligometastatic Prostate Cancer (OMPC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Wisconsin - Madison, Madison, Wisconsin, United States
Contact: Study coordinator (Cancer Connect) · clinicaltrials@cancer.wisc.edu · 800-622-8922
Contact: Principal Investigator (John Floberg, MD, PhD)

Study leads

Douglas McNeel, MD, PhD
Principal Investigator
University of Wisconsin, Madison

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

Healthy Adult · Prostate Cancer

Abroad (travel likely)RecruitingEARLY_PHASE1

Guangzhou, China

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Advanced Solid Cancer · Metastatic Solid Tumor · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Zhengzhou, China · Shanghai, China

Transperineal Versus Transrectal Cognitive Fusion Prostate Biopsy

Prostate Cancer · Clinically Significant Prostate Cancer · Cognitive Fusion

Abroad (travel likely)Recruiting

Ankara, Turkey (Türkiye)

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

Prostate Cancer

Abroad (travel likely)Recruiting

Bethesda, United States